To further elucidate the effects of tilianin on inhibiting NLRP3 inflammasome activation, we established an H9c2 cellular oxygen-glucose deprivation/reperfusion model to simulate the myocardial ischemia-reperfusion injury. The gene discussed is NLRP3; the disease is myocardial ischemia.